Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Major advance in thalassemia research reported

Oct. 24, 1997

Lower dose version of Caverject introduced

Oct. 23, 1997

Viagra awarded priority review status by FDA

Oct. 23, 1997

Role of angiotensin II in erectile function investigated

Oct. 23, 1997

Trazodone evaluated in patients with erectile dysfunction

Oct. 23, 1997

rhIGF-1 improves lipid profiles in adults with IDDM

Oct. 23, 1997

Ligand and Lilly enter drug discovery and development alliance for metabolic drugs

Oct. 23, 1997

Endocrinologic and Metabolic Drugs Advisory Committee meets in late November

Oct. 22, 1997

Mechanism of cytoprotective effects of bimoclomol

Oct. 22, 1997

Identification of metabolites of Sch-48461 leads to potent cholesterol absorption inhibitor

Oct. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...